Lipids, glucose and iron metabolic alterations in chronic hepatitis C after viral eradication – comparison of the new direct-acting antiviral agents with the old regimens-Reference-Cited by-同舟云学术

Lipids, glucose and iron metabolic alterations in chronic hepatitis C after viral eradication – comparison of the new direct-acting antiviral agents with the old regimens

Published:2018-05-20 Issue:7 Volume:53 Page:857-863
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Carvalho Joana Rita¹,Velosa José¹,Serejo Fátima¹

Affiliation:

1. Department of Gastroenterology and Hepatology, North Lisbon Hospital Center, University of Lisbon, Lisboa, Portugal

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2018.1473486

Reference69 articles.

1. Diagnosis, management, and treatment of hepatitis C: An update

2. Hepatitis C eradication with sofosbuvir leads to significant metabolic changes

3. Understanding the hepatitis C virus life cycle paves the way for highly effective therapies

4. O impacto da hepatite C em Portugal

5. Chronic hepatitis C virus infection and lipoprotein metabolism

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Hepatitis C Virus Infection, Extrahepatic Disease and the Impact of New Direct-Acting Antivirals;Pathogens;2024-04-19

2. Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antivirals;Journal of Gastroenterology;2024-04-13

3. Lipid Profile and Cardiovascular Risk Modification after Hepatitis C Virus Eradication;Pathogens;2024-03-25

4. Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: A systematic review;Liver International;2024-02-22

5. Safety and efficacy of combined dual antiplatelet therapy and factor VIII prophylaxis in patients with haemophilia A after acute coronary syndrome;Haemophilia;2024-02-20